
The production capacity of the drug has crossed 1.05 crore vials per month as on May 4, a nearly three-fold increase from 37 lakh vials per month on April 12 this year, Mandaviya said in a tweet. The minister said the antiviral drug is now being produced across 57 plants in the country compared to 20 facilities a month ago.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3edUuar
via
IFTTT
0 comments:
Post a Comment